<DOC>
	<DOC>NCT02815800</DOC>
	<brief_summary>ETHNODYNE VISIO is a food supplement composed of an innovative plant-based active ingredient acting alongside vitamin B2. It is proposed in patients with visual problems. Based on clinical and experimental data, the investigators propose a pilot open study in order to test the efficacy of "Ethnodyne visio" in patients with Parkinson 's disease (PD). The hypothesis is that Ethnodyne visio may improve motor and non motor signs of PD. 24 patients with PD will be evaluated before and after 3 months of add on treatment by Ethnodyne visio.</brief_summary>
	<brief_title>Efficacy of Ethnodyne Visio in Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients with Parkinson disease (PD) with at least 3 years of evolution Hoehn and Yahr score 2 or 3 with moderate fluctuations (score 1 or 2 for item 3 score IV MSD UPDRS) with no modification in antiparkinsonian drugs since at least 1 month minimental test &gt;24 known intolerance to Ethnodyne visio woman of childbearing potential or breastfeeding anticipated antiparkinsonian treatment modification during the 3 months of the study antidepressant or anxiolytic drugs modified within one month prior to inclusion visit other chronic disease concomitant participation in a another clinical trial Subject under legal guardianship</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Motor signs</keyword>
	<keyword>Non motor signs</keyword>
	<keyword>Fluctuations</keyword>
	<keyword>Open labelled</keyword>
</DOC>